EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids from Gynura segetum: Mechanisms and Therapeutic Advances

Zheng Zhou, Dongfan Yang, Tong Chu iD, Dayuan Zheng, Kuanyun Zhang, Shaokui Liang, Lu Yang, Yanchao Yang, Wenzhe Ma iD

Molecules · 25.01.2026 · 31 (3) · 410

DOI: 10.3390/molecules31030410 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 25.01.2026. Verfasst von Zheng Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Mechanism and Quality of Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR…. Hauptthemen laut MEDLINE: Pyrrolizidine Alkaloids, Hepatic Veno-Occlusive Disease, Asteraceae, Drugs, Chinese Herbal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Fund, Science and Technology Development Fund, Macau SAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The traditional Chinese medicinal herb Gynura segetum is increasingly recognized for its hepatotoxic potential, primarily attributed to its pyrrolizidine alkaloid (PA) content. PAs are a leading cause of herb-induced liver injury (HILI) in China and are strongly linked to hepatic sinusoidal obstruction syndrome (HSOS). This review systematically summarizes the pathogenesis, diagnostic advancements, and therapeutic strategies for PA-induced HSOS. Molecular mechanisms of PA metabolism are detailed, encompassing cytochrome P450-mediated bioactivation and the subsequent formation of pyrrole-protein adducts, which trigger sinusoidal endothelial cell injury and hepatocyte apoptosis. Advances in diagnostic criteria, including the Nanjing Criteria and the Roussel Uclaf Causality Assessment Method (RUCAM)-integrated Drum Tower Severity Scoring System, are discussed. Furthermore, emerging biomarkers, such as circulating microRNAs and pyrrole-protein adducts, are examined. Imaging modalities, such as contrast-enhanced computed tomography (CT) and gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) magnetic resonance imaging (MRI), have evolved from descriptive tools into quantitative and prognostic instruments. Therapeutic approaches have evolved from supportive care to precision interventions, including anticoagulation, transjugular intrahepatic portosystemic shunt (TIPS), and autophagy-modulating agents. A comprehensive literature review, utilizing databases such as PubMed and Web of Science, was conducted to summarize progress since the introduction of the “Nanjing Guidelines”. Ultimately, this review underscores the critical need for integrated diagnostic and therapeutic frameworks, alongside enhanced public awareness and regulatory oversight, to effectively mitigate PA-related liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pyrrolizidine AlkaloidsHepatic Veno-Occlusive DiseaseAsteraceaeDrugs, Chinese HerbalHumansAnimalsBiomarkers

Stichwörter der Autor:innen

Gynura segetumRUCAMhepatic sinusoidal obstruction syndromemechanismpyrrolizidine alkaloidstherapeutic treatment

Substanzen

Pyrrolizidine AlkaloidsDrugs, Chinese HerbalBiomarkers

Autor:innen und Institutionen

  • State Key Laboratory of Mechanism and Quality of Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR 999078, China.
  • Zhuhai MUST Science and Technology Research Institute, Macau University of Science and Technology, Hengqin Guangdong-Macao In-Depth Cooperation Zone, Zhuhai 519099, China.

ORCID-Profile: Tong Chu, Wenzhe Ma

Förderung

  • Science and Technology Development Fund
  • Science and Technology Development Fund, Macau SAR

Zitieren

APA

Zhou, Z., Yang, D., Chu, T., Zheng, D., Zhang, K., Liang, S., Yang, L., Yang, Y., & Ma, W. (2026). Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids from Gynura segetum: Mechanisms and Therapeutic Advances. Molecules, 31(3), 410. https://doi.org/10.3390/molecules31030410

Vancouver

Zhou Z, Yang D, Chu T, Zheng D, Zhang K, Liang S, et al. Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids from Gynura segetum: Mechanisms and Therapeutic Advances. Molecules. 2026;31(3):410. doi:10.3390/molecules31030410

BibTeX
@article{Zhou2026,
  author = {Zhou, Zheng and Yang, Dongfan and Chu, Tong and Zheng, Dayuan and Zhang, Kuanyun and Liang, Shaokui and Yang, Lu and Yang, Yanchao and Ma, Wenzhe},
  title = {Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids from Gynura segetum: Mechanisms and Therapeutic Advances},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {3},
  pages = {410},
  doi = {10.3390/molecules31030410}
}
Kostenlos starten →